Pantoprazole Dosage
Medically reviewed by Drugs.com. Last updated on Jan 4, 2021.
Applies to the following strengths: 40 mg; 20 mg
Usual Adult Dose for:
- Erosive Esophagitis
- Gastroesophageal Reflux Disease
- Zollinger-Ellison Syndrome
- Pathological Hypersecretory Conditions
Usual Pediatric Dose for:
Additional dosage information:
Usual Adult Dose for Erosive Esophagitis
Treatment: 40 mg orally once a day
-Duration of therapy: 8 weeks
Maintenance: 40 mg orally once daily
Comments:
-If patients are not healed after 8 weeks or erosive esophagitis (EE) recurs with the oral formulation, treatment for another 8 weeks may be considered.
-Controlled studies using the oral formulation for maintenance did not extend beyond 12 months.
Uses:
-Short-term treatment in the healing and symptomatic relief of EE
-Maintenance of healing of EE
Usual Adult Dose for Gastroesophageal Reflux Disease
Oral: 40 mg orally once a day
-Duration of therapy: 8 weeks
Parenteral: 40 mg via IV infusion once a day, given over at least 2 minutes OR over 15 minutes
-Duration of therapy: 7 to 10 days
Comments:
-IV treatment should be discontinued once the patient is able to take an oral formulation.
-Use of the IV formulation has not been studied for longer than 10 days.
-Safety and efficacy for uses otherwise described (e.g., life-threatening gastrointestinal bleeds) are not available; however, use of this drug at 40 mg/day doses did not raise gastric pH to sufficient levels to contribute to the treatment of life-threatening conditions.
-If patients are not healed after 8 weeks with the oral formulation, treatment for another 8 weeks may be considered.
Uses:
-Short-term treatment of gastroesophageal reflux disease (GERD) in patients with a history of erosive esophagitis
-Reduction of relapse rates of daytime and nighttime heartburn symptoms in adult patients with GERD
Usual Adult Dose for Zollinger-Ellison Syndrome
Oral: 40 mg orally 2 times a day
-Maximum dose: 240 mg/day
Parenteral:
-Initial dose: 80 mg via IV infusion every 12 hours, given over at least 2 minutes OR over 15 minutes
-Maintenance dose: 80 mg via IV infusion every 8 to 12 hours, given over at least 2 minutes OR over 15 minutes
-Maximum dose: 240 mg/day
-Maximum duration of therapy: 6 days
Comments:
-IV treatment should be discontinued once the patient is able to take an oral formulation.
-Use of the IV formulation for longer than 6 days and/or with doses higher than 240 mg has not been adequately studied.
-Patients may be vulnerable to increased acid production despite a short period of loss of effective inhibition.
-Patients given the oral formulation should be continued on therapy for as long as clinically necessary.
Uses:
-Treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome
-Pathological hypersecretion conditions, including Zollinger-Ellison syndrome
Usual Adult Dose for Pathological Hypersecretory Conditions
Oral: 40 mg orally 2 times a day
-Maximum dose: 240 mg/day
Parenteral:
-Initial dose: 80 mg via IV infusion every 12 hours, given over at least 2 minutes OR over 15 minutes
-Maintenance dose: 80 mg via IV infusion every 8 to 12 hours, given over at least 2 minutes OR over 15 minutes
-Maximum dose: 240 mg/day
-Maximum duration of therapy: 6 days
Comments:
-IV treatment should be discontinued once the patient is able to take an oral formulation.
-Use of the IV formulation for longer than 6 days and/or with doses higher than 240 mg has not been adequately studied.
-Patients may be vulnerable to increased acid production despite a short period of loss of effective inhibition.
-Patients given the oral formulation should be continued on therapy for as long as clinically necessary.
Uses:
-Treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome
-Pathological hypersecretion conditions, including Zollinger-Ellison syndrome
Usual Pediatric Dose for Erosive Esophagitis
5 years and older:
15 to less than 40 kg: 20 mg orally once a day
40 kg and greater: 40 mg orally once a day
Duration of therapy: Up to 8 weeks
Comment: Safety has not been established in treatment beyond 8 weeks.
Uses:
-Short-term treatment in the healing and symptomatic relief of EE
-Short-term treatment of GERD in patients with a history of EE
Usual Pediatric Dose for Gastroesophageal Reflux Disease
5 years and older:
15 to less than 40 kg: 20 mg orally once a day
40 kg and greater: 40 mg orally once a day
Duration of therapy: Up to 8 weeks
Comment: Safety has not been established in treatment beyond 8 weeks.
Uses:
-Short-term treatment in the healing and symptomatic relief of EE
-Short-term treatment of GERD in patients with a history of EE
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
IV: Data not available
Oral: Doses over 40 mg/day have not been studied in patients with liver impairment. No adjustment recommended.
Dose Adjustments
CYP450 2C19 Poor Metabolizers:
Adults: No adjustment recommended.
Pediatric patients: Oral dose reductions should be considered.
Pathological Hypersecretion (including Zollinger-Ellison syndrome):
-Acid output target range: Less than 10 mEq/h
Precautions
CONTRAINDICATIONS:
-Hypersensitivity to the active component, substituted benzimidazoles, or any of the ingredients
-Patients receiving rilpivirine-containing products
Safety and efficacy of oral formulations have not been established in patients younger than 5 years. The IV formulation is not recommended for use in children.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
-Tablet formulations should be swallowed whole, without crushing/chewing; tablets may be taken with or without food.
-For patients unable to swallow a 40 mg tablet, two 20 mg tablets may be taken; however, the 40 mg oral suspension packet formulation should not be divided to create two-20 mg dosages.
-Oral suspension/granule formulations should be taken on an empty stomach, preferably 30 to 60 minutes before a meal.
-The granule formulation may be sprinkled into applesauce or mixed into a small volume of either apple juice or orange juice and swallowed immediately. This drug may be mixed with apple juice and administered via nasogastric tube.
Storage requirements: The manufacturer product information should be consulted.
Reconstitution/preparation techniques: The manufacturer product information should be consulted.
IV compatibility: The manufacturer product information should be consulted.
General:
-This drug may be used concomitantly with antacids without affecting the absorption.
-Reflux symptoms may take 2 to 3 days to improve after initiation.
-Rapid acid control may be achieved within an hour at an IV dose of 160 mg.
Monitoring:
-HEPATIC: Liver function tests, especially in patients with impaired liver function
-METABOLIC: Magnesium levels, especially in patients taking other drugs that could result in hypomagnesemia or those on long-term therapy; Vitamin B12 levels, especially in patients on long-term therapy
-MUSCULOSKELETAL: Bone fractures, especially in patients at high-risk for osteoporosis-related events
-RENAL: Renal function tests
Patient advice:
-Advise patients to avoid taking concomitant proton pump inhibitors and/or H2 antagonists during treatment.
-If using this drug to treat H pylori, tell patients that it is important to complete the full regimen.
-Instruct patients to seek medical attention if signs/symptoms of hypersensitivity, Clostridium difficile, or systemic cutaneous lupus erythematosus occur.
-Patients should be told that treatment may not provide immediate relief and that they should not take this drug for prophylaxis. Symptomatic relief may occur after 1 day of treatment, but patients should continue treatment for the full duration to achieve complete symptom control.
-Inform patients that this drug may cause dizziness or blurred vision, and they should avoid driving or operating machinery if these side effects occur.
-Advise patients to speak to their healthcare provider if they become pregnant, intend to become pregnant, or are breastfeeding.
Frequently asked questions
- Pantoprazole vs. omeprazole: What's the difference between them?
- Can you take pantoprazole 40 mg twice a day?
- How long can I take pantoprazole?
- Does pantoprazole cause bloating?
More about pantoprazole
- Side effects
- Drug interactions
- During pregnancy or Breastfeeding
- Reviews (383)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: proton pump inhibitors
Patient resources
- Drug Information
- Pantoprazole (Advanced Reading)
- Pantoprazole Intravenous (Advanced Reading)
- Pantoprazole Delayed-Release Granules
- Pantoprazole Delayed-Release Tablets
- Pantoprazole Injection
- Other brands
- Protonix, Protonix IV
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.